West Pharmaceutical Services Declares $0.22 Quarterly Dividend
Shareholders of West Pharmaceutical Services will receive a regular quarterly dividend of $0.22 per share following a decision by the company’s Board of Directors on July 21. The payout is scheduled for distribution on August 5 to all investors of record as of the close of business on July 29.
The Exton, Pennsylvania-based company maintains a significant global footprint in the injectable drug administration sector. Operating 26 manufacturing facilities across 50 international sites, the firm produces over 41 billion components and devices annually to support its network of drug developers.
West Pharmaceutical Services, which generated $3.07 billion in net sales during fiscal year 2025, continues to focus on the containment and delivery of medical treatments. The company remains a component of the Standard & Poor's 500 index and trades on the New York Stock Exchange under the ticker symbol WST.
Comments (0)
No comments yet. Be the first!